Absent or hypoplastic nasal bone: What to tell the prospective parents?
- PMID: 38801241
- DOI: 10.1002/bdr2.2348
Absent or hypoplastic nasal bone: What to tell the prospective parents?
Abstract
Background: Absent or hypoplastic nasal bone (AHNB) on first or second-trimester ultrasonography (USG) is an important soft marker of Down syndrome. However, due to its varied incidence in euploid and aneuploid fetuses, there is always a dilemma of whether to go for invasive fetal testing for isolated AHNB. This study aims to assess outcomes specifically within the context of Indian ethnicity women.
Materials and methods: This was a prospective observational study. All patients who reported with AHNB in the first- or second-trimester USG were included. Genetic counseling was done, and noninvasive and invasive testing was offered. Chromosomal anomalies were meticulously recorded, and pregnancy was monitored.
Results: The incidence of AHNB in our study was 1.16% (47/4051). Out of 47 women with AHNB, the isolated condition was seen in 32 (0.78%) cases, while AHNB with structural anomalies was seen in nine cases (0.22%). Thirty-nine women opted for invasive testing. Six out of 47 had aneuploidy (12.7%), while two euploid cases (4.25%) developed nonimmune hydrops. The prevalence of Down syndrome in fetuses with AHNB was 8.5% (4/47) and 0.42% (17/4004) in fetuses with nasal bone present. This difference was statistically significant (p = .001).
Conclusion: The results indicate that isolated AHNB cases should be followed by a comprehensive anomaly scan rather than immediately recommending invasive testing. However, invasive testing is required when AHNB is associated with other soft markers or abnormalities. As chromosomal microarray is more sensitive than standard karyotype in detecting chromosomal aberrations, it should be chosen over karyotype.
Keywords: Down syndrome (DS); absent or hypoplastic nasal bone; amniocentesis; aneuploidy; karyotype; microarray; soft markers.
© 2024 Wiley Periodicals LLC.
References
REFERENCES
-
- Agathokleous, M., Chaveeva, P., Poon, L. C. Y., Kosinski, P., & Nicolaides, K. H. (2013). Meta‐analysis of second‐trimester markers for trisomy 21. Ultrasound in Obstetrics & Gynecology, 41(3), 247–261. https://doi.org/10.1002/uog.12364
-
- Akalın, M., Demirci, O., Dizdaroğulları, G. E., Çiftçi, E., & Karaman, A. (2023). Contribution of chromosomal microarray analysis and next‐generation sequencing to genetic diagnosis in fetuses with normal karyotype. The Journal of Obstetrics and Gynaecology Research, 49(2), 519–529. https://doi.org/10.1111/jog.15486
-
- Alfirevic, Z., Navaratnam, K., & Mujezinovic, F. (2017). Amniocentesis and chorionic villus sampling for prenatal diagnosis. The Cochrane Database of Systematic Reviews, 9(9), CD003252. https://doi.org/10.1002/14651858.CD003252.pub2
-
- Bansal, V., & Jhaveri, R. (2022). Prenatal invasive testing at a tertiary referral Center in India: A report of 433 cases under a single operator. Journal of Obstetrics and Gynaecology of India, 72(1), 47–58. https://doi.org/10.1007/s13224-021-01496-9
-
- Benacerraf, B. R., Bromley, B., & Jelin, A. C. (2019). Absent nasal bone. American Journal of Obstetrics and Gynecology, 221(5), B6–B7. https://doi.org/10.1016/j.ajog.2019.08.049
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials